← MyLongPath

Lithium (microdose)

MedicationExperimental0 reviews
Average score out of 5
ExperimentalThis treatment is under research. Available data is limited. Consult your doctor before making any decision.

Low-dose lithium is being investigated for its potential neuroprotective and anti-inflammatory effects, which may help alleviate neurological and cognitive symptoms of Long COVID.

Information
Subcategory
mood stabilizer / neuroprotective
Evidence level
2/5
Evidence type
preclinical data and mechanistic rationale
Share your experience

Your feedback helps thousands of people find what really works.

Join the community